HK1212975A1 - 作為布魯頓氏酪氨酸激酶抑制劑的噻唑衍生物 - Google Patents
作為布魯頓氏酪氨酸激酶抑制劑的噻唑衍生物Info
- Publication number
- HK1212975A1 HK1212975A1 HK16100856.5A HK16100856A HK1212975A1 HK 1212975 A1 HK1212975 A1 HK 1212975A1 HK 16100856 A HK16100856 A HK 16100856A HK 1212975 A1 HK1212975 A1 HK 1212975A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- inhibitors
- tyrosine kinase
- thiazole derivatives
- brutons tyrosine
- brutons
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Transplantation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201261736631P | 2012-12-13 | 2012-12-13 | |
PCT/EP2013/075887 WO2014090715A1 (en) | 2012-12-13 | 2013-12-09 | Thiazole derivatives as inhibitors of bruton's tyrosine kinase |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1212975A1 true HK1212975A1 (zh) | 2016-06-24 |
Family
ID=49765484
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK16100856.5A HK1212975A1 (zh) | 2012-12-13 | 2016-01-26 | 作為布魯頓氏酪氨酸激酶抑制劑的噻唑衍生物 |
Country Status (12)
Country | Link |
---|---|
US (1) | US9359345B2 (zh) |
EP (1) | EP2931721B1 (zh) |
JP (1) | JP6154482B2 (zh) |
KR (1) | KR101707761B1 (zh) |
CN (1) | CN104837837B (zh) |
BR (1) | BR112015013762A2 (zh) |
CA (1) | CA2893637A1 (zh) |
ES (1) | ES2607635T3 (zh) |
HK (1) | HK1212975A1 (zh) |
MX (1) | MX2015007291A (zh) |
RU (1) | RU2015126293A (zh) |
WO (1) | WO2014090715A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11655246B2 (en) | 2017-11-30 | 2023-05-23 | Step Pharma S.A.S. | Aminothiazole compounds as inhibitors of CTPS1 |
EP3492454A1 (en) * | 2017-11-30 | 2019-06-05 | Step Pharma S.A.S. | Compounds |
US11505547B2 (en) | 2017-11-30 | 2022-11-22 | Step Pharma S.A.S. | Compounds |
JP7084586B2 (ja) | 2018-01-15 | 2022-06-15 | 国立研究開発法人産業技術総合研究所 | 単結晶ダイヤモンド基板を含む積層体 |
DK3870574T3 (da) | 2018-10-23 | 2023-04-11 | Step Pharma S A S | Aminopyridin/pyrazinderivater som ctps1-inhibitorer |
CA3160447A1 (en) * | 2019-11-06 | 2021-05-14 | Albert Einstein College Of Medicine | Small molecule prostagladin transport inhibitors |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011518221A (ja) * | 2008-04-21 | 2011-06-23 | メルク・シャープ・エンド・ドーム・コーポレイション | Janusキナーゼの阻害剤 |
WO2010068788A1 (en) * | 2008-12-10 | 2010-06-17 | Cgi Pharmaceuticals, Inc. | Heterocyclic amides as btk inhibitors |
-
2013
- 2013-12-09 WO PCT/EP2013/075887 patent/WO2014090715A1/en active Application Filing
- 2013-12-09 CA CA2893637A patent/CA2893637A1/en not_active Abandoned
- 2013-12-09 EP EP13805327.7A patent/EP2931721B1/en not_active Not-in-force
- 2013-12-09 CN CN201380064712.3A patent/CN104837837B/zh not_active Expired - Fee Related
- 2013-12-09 MX MX2015007291A patent/MX2015007291A/es unknown
- 2013-12-09 ES ES13805327.7T patent/ES2607635T3/es active Active
- 2013-12-09 KR KR1020157018616A patent/KR101707761B1/ko active IP Right Grant
- 2013-12-09 JP JP2015546962A patent/JP6154482B2/ja not_active Expired - Fee Related
- 2013-12-09 BR BR112015013762A patent/BR112015013762A2/pt not_active IP Right Cessation
- 2013-12-09 RU RU2015126293A patent/RU2015126293A/ru not_active Application Discontinuation
- 2013-12-09 US US14/648,296 patent/US9359345B2/en not_active Expired - Fee Related
-
2016
- 2016-01-26 HK HK16100856.5A patent/HK1212975A1/zh not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
KR20150093238A (ko) | 2015-08-17 |
CN104837837A (zh) | 2015-08-12 |
RU2015126293A (ru) | 2017-01-19 |
CN104837837B (zh) | 2017-04-05 |
JP2016502988A (ja) | 2016-02-01 |
JP6154482B2 (ja) | 2017-06-28 |
US20150353534A1 (en) | 2015-12-10 |
KR101707761B1 (ko) | 2017-02-16 |
ES2607635T3 (es) | 2017-04-03 |
EP2931721A1 (en) | 2015-10-21 |
US9359345B2 (en) | 2016-06-07 |
BR112015013762A2 (pt) | 2017-07-11 |
CA2893637A1 (en) | 2014-06-19 |
WO2014090715A1 (en) | 2014-06-19 |
MX2015007291A (es) | 2015-09-10 |
EP2931721B1 (en) | 2016-10-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL263262B (en) | Atr kinase inhibitor compounds, preparations containing them, their uses and methods for their preparation | |
HRP20181429T8 (hr) | Novi derivati benzimidazola kao inhibitori kinaze | |
HK1212689A1 (zh) | 布魯頓氏酪氨酸激酶抑制劑 | |
HK1194381A1 (zh) | 酪氨酸激酶抑制劑 | |
HK1211293A1 (zh) | 布魯頓氏酪氨酸激酶抑制劑 | |
HK1197060A1 (zh) | 酪氨酸激酶抑制劑 | |
HK1210161A1 (zh) | 用作布魯頓酪氨酸激酶 抑制劑的雜芳族化合物 | |
SG11201600062RA (en) | Pyrimidine derivatives as kinase inhibitors | |
HK1208803A1 (zh) | 布魯頓酪氨酸激酶抑制劑的晶形 | |
HK1186186A1 (zh) | 酪氨酸蛋白激酶抑制劑 | |
HK1208442A1 (zh) | 作為 激酶抑制劑的取代的吡咯並嘧啶基氨基-苯並噻唑酮 | |
HK1210779A1 (zh) | 酪氨酸激酶抑制劑 | |
HK1210461A1 (zh) | 布魯頓氏酪氨酸激酶抑制劑 | |
HK1200816A1 (zh) | 布魯頓酪氨酸激酶抑制劑 | |
HK1205116A1 (zh) | 作為磷酸二酯酶抑制劑的 -苯基- -吡啶基烷基醇的衍生物 | |
HK1212975A1 (zh) | 作為布魯頓氏酪氨酸激酶抑制劑的噻唑衍生物 | |
IL243295A0 (en) | Carbazole carboxamide compounds are useful as kinase inhibitors | |
HK1217695A1 (zh) | 布魯頓氏酪氨酸激酶抑制劑 | |
EP2861562A4 (en) | PYRAZOL DERIVATIVES AS INHIBITORS OF STAT3 | |
HK1218416A1 (zh) | 布魯頓氏酪氨酸激酶抑制劑 | |
EP2838531A4 (en) | INDOLIN-2-ONE DERIVATIVES AS INHIBITORS OF PROTEIN KINASES | |
HK1215855A1 (zh) | 酪氨酸蛋白激酶抑制劑 | |
HK1203931A1 (zh) | -吲唑- -甲酰胺化合物作為糖原合酶激酶 β抑制劑的用途 | |
HK1210036A1 (zh) | 作為蛋白激酶抑制劑的氨基異喹啉衍生物 | |
EP2968331A4 (en) | PYRROLOPYRIMIDINE COMPOUNDS AS KINASEINHIBITORS |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20211204 |